GoodRx Holdings, Inc. (GDRX) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $2.23. It has a SharesGrow Score of 57/100, indicating a above average investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of GDRX = $20.31 (+810.8% from the current price, the stock appears undervalued). Analyst consensus target is GDRX = $3 (+43% upside).
Valuation: GDRX trades at a trailing Price-to-Earnings (P/E) of 23.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.47.
Financials: revenue is $797M, +1.4%/yr average growth. Net income is $30M, growing at +147.8%/yr. Net profit margin is 3.8% (thin). Gross margin is 82.1% (-9.4 pp trend).
Balance sheet: total debt is $60M against $616M equity (Debt-to-Equity (D/E) ratio 0.1, conservative). Current ratio is 2.61 (strong liquidity). Debt-to-assets is 4.2%. Total assets: $1.4B.
Analyst outlook: 10 / 24 analysts rate GDRX as buy (42%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 78/100 (Pass), Growth 73/100 (Pass), Past 50/100 (Partial), Health 67/100 (Partial), Moat 49/100 (Partial), Future 52/100 (Partial), Income 30/100 (Fail).
